The University of Chicago Header Logo

Connection

Mark Talamonti to Carcinoma, Pancreatic Ductal

This is a "connection" page, showing publications Mark Talamonti has written about Carcinoma, Pancreatic Ductal.
Connection Strength

3.495
  1. Modern Treatment Strategies for Borderline Resectable Pancreatic Cancer. Cancer Treat Res. 2024; 192:67-88.
    View in: PubMed
    Score: 0.743
  2. Postoperative venous thromboembolism and mortality in patients with pancreatic surgery. J Surg Oncol. 2019 Sep; 120(3):494-500.
    View in: PubMed
    Score: 0.543
  3. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007 Oct; 142(4):529-34; discussion 534-7.
    View in: PubMed
    Score: 0.241
  4. Multimodal Therapy May be Key to Improving Survival for Octogenarians Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: An American Multicenter Analysis. Ann Surg Oncol. 2025 May; 32(5):3582-3592.
    View in: PubMed
    Score: 0.200
  5. Extended postoperative thromboprophylaxis after pancreatic resection for pancreatic cancer is associated with decreased risk of venous thromboembolism in the minimally invasive approach. J Surg Oncol. 2023 Mar; 127(3):413-425.
    View in: PubMed
    Score: 0.172
  6. Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? Surgery. 2018 05; 163(5):1047-1052.
    View in: PubMed
    Score: 0.123
  7. The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy. HPB (Oxford). 2018 02; 20(2):140-146.
    View in: PubMed
    Score: 0.122
  8. Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
    View in: PubMed
    Score: 0.121
  9. Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy. J Gastrointest Surg. 2017 Oct; 21(10):1620-1625.
    View in: PubMed
    Score: 0.119
  10. Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience. Ann Surg Oncol. 2017 Sep; 24(9):2770-2776.
    View in: PubMed
    Score: 0.118
  11. A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy. Ann Surg. 2016 Oct; 264(4):640-9.
    View in: PubMed
    Score: 0.112
  12. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg. 2016 08 17; 151(8):e161137.
    View in: PubMed
    Score: 0.111
  13. The Learning Curve Is Surmountable: In Reply to Fong and colleagues. J Am Coll Surg. 2016 Feb; 222(2):210-1.
    View in: PubMed
    Score: 0.107
  14. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015 Oct; 47(10):1168-78.
    View in: PubMed
    Score: 0.104
  15. Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base. J Am Coll Surg. 2015 Jul; 221(1):175-84.
    View in: PubMed
    Score: 0.102
  16. The laparoscopic approach to distal pancreatectomy for ductal adenocarcinoma results in shorter lengths of stay without compromising oncologic outcomes. Am J Surg. 2015 Mar; 209(3):557-63.
    View in: PubMed
    Score: 0.099
  17. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut. 2012 Oct; 61(10):1454-64.
    View in: PubMed
    Score: 0.081
  18. A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med. 2010 Jul 13; 7(7):e1000307.
    View in: PubMed
    Score: 0.073
  19. Mucinous nonneoplastic cyst of the pancreas: apomucin phenotype distinguishes this entity from intraductal papillary mucinous neoplasm. Hum Pathol. 2010 Apr; 41(4):513-21.
    View in: PubMed
    Score: 0.070
  20. Methylation profile of circulating plasma DNA in patients with pancreatic cancer. J Surg Oncol. 2009 Feb 01; 99(2):119-22.
    View in: PubMed
    Score: 0.066
  21. Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching. J Surg Oncol. 2020 Aug; 122(2):183-194.
    View in: PubMed
    Score: 0.036
  22. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg. 2008 Dec; 12(12):2078-86.
    View in: PubMed
    Score: 0.016
  23. Clear cell carcinoma of the pancreas: histopathologic features and a unique biomarker: hepatocyte nuclear factor-1beta. Mod Pathol. 2008 Sep; 21(9):1075-83.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.